Access cutting-edge neonatal seizures treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access neonatal seizures specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neonatal seizures treatment provided free
The main purpose of this study is to determine the maximum safe tolerated dose of LEV in the treatment of neonatal seizures. Our hypothesis is that optimal dosing of Levetiracetam (LEV) to treat neonatal seizures is significantly greater than 60mg/kg. This study will be an open label dose-escalation, preliminary safety and efficacy study. There will be a randomized control treatment component. Infants recognized as having neonatal seizures or as being at risk of developing seizures will be recru
Sponsor: University of California, San Diego
Check if you qualify for this neonatal seizures clinical trial in Minneapolis, MN
If you're searching for neonatal seizures treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neonatal seizures specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.